by Clinical Neuropsychologist Online | Saturday, March 29, 2025 | Dementia
Abstract INTRODUCTION This study was undertaken to evaluate the diagnostic performance of a novel plasma phosphorylated tau (p-tau) 217/amyloid beta (Aβ) 42 ratio test for Alzheimer’s disease (AD). METHODS The diagnostic performance of the Lumipulse G plasma...
by Clinical Neuropsychologist Online | Saturday, March 29, 2025 | Dementia
Abstract INTRODUCTION It is unclear whether aggregated plasma protein risk scores (PPRSs) could be useful in predicting the risks of mild cognitive impairment (MCI) and Alzheimer’s disease (AD). METHODS The Cox proportional hazard model with the Least Absolute...
by Clinical Neuropsychologist Online | Saturday, March 29, 2025 | Dementia
Abstract INTRODUCTION Accountable care organizations (ACOs) are well positioned to promote care coordination. However, robust evidence of ACOs’ impact on Medicare payments for residents with Alzheimer’s disease and related dementias (ADRD) in disadvantaged...
by Clinical Neuropsychologist Online | Saturday, March 29, 2025 | Dementia
Abstract INTRODUCTION It is unknown how prepared primary care practices are to deliver recommended dementia care. METHODS A nationally representative survey of US primary care practices focused on care delivery processes, including those for patients with...
by Clinical Neuropsychologist Online | Saturday, March 29, 2025 | Dementia
Abstract INTRODUCTION Medicare’s new Guiding an Improved Dementia Experience (GUIDE) model funds integrated dementia care and related caregiver supports for community-living persons with dementia (PwD). Caregiver strain is a factor in provider payment and...
